Deltalin

ANDA 80884, held by Lilly. Ergocalciferol.

As of Nov 15, 2026, ANDA 80884 (Deltalin), held by Lilly, was first approved by FDA on Jun 12, 1973, with 2 approved supplements and 0 published complete response letters.

First approved: Jun 12, 1973
Supplements approved: 2
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 3 submissions below

Date	Submission	Status	Documents
Jun 12, 1973	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Deltalin50,000 IU · capsule;oral	Ergocalciferol	Discontinued

All 3 submissions, including labeling and manufacturing supplements


Jan 15, 1991	Supplement 10Labeling	Approved	None posted
Oct 18, 1985	Supplement 9Labeling	Approved	None posted
Jun 12, 1973	Original application	Approved	None posted

Identifiers

Application: ANDA 80884
Drugs@FDA: Overview at FDA
Company: Lilly

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters